Seketsu Fukuzawa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Seketsu Fukuzawa has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Akiko Nagata
Department of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, Koganei, Tokyo 184-8588, Japan
1 shared publication Kazuo Nagasawa
Department of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, Tokyo, Japan
1 shared publication- Kazuo Nagasawa
Department of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, Koganei, Tokyo 184-8588, Japan
1 shared publication - Kazuto Iijima
Department of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, Koganei, Tokyo 184-8588, Japan
1 shared publication Koji Takahashi
Marketing Department, ME Business Operations, JEOL Ltd., Tokyo, Japan; Department of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, Tokyo, Japan
1 shared publicationMasaki Takiwaki
Marketing Department, ME Business Operations, JEOL Ltd., Tokyo, Japan
1 shared publication
Latest Publications
- Open Access
- 18 August 2025
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 266, 117125
Chromatographic separation of dihydroxylated vitamin D3 and accurate quantification of 1α,25(OH)2D3 in human serum
- 18 August 2025
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 266, 117125
Open AccessChromatographic separation of dihydroxylated vitamin D3 and accurate quantification of 1α,25(OH)2D3 in human serum
- Open Access
Synthesis of Deuterium-Labeled Vitamin D Metabolites as Internal Standards for LC-MS Analysis
Blood levels of the vitamin D3 (D3) metabolites 25-hydroxyvitamin D3 (25(OH)D3), 24R,25-dihydroxyvitamin D3, and 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3) are recognized indicators for the diagnosis of bone metabolism-related diseases, D3 deficiency-related diseases, and hypercalcemia, and are generally measured by liquid-chromatography tandem mass spectrometry (LC-MS/MS) using an isotope dilution method. However, other D3 metabolites, such as 20-hydroxyvitamin D3 and lactone D3, also show interesting biological activities and stable isotope-labeled derivatives are required for LC-MS/MS analysis of their concentrations in serum. Here, we describe a versatile synthesis of deuterium-labeled D3 metabolites using A-ring synthons containing three deuterium atoms. Deuterium-labeled 25(OH)D3 (2), 25(OH)D3-23,26-lactone (6), and 1,25(OH)2D3-23,26-lactone (7) were synthesized, and successfully applied as internal standards for the measurement of these compounds in pooled human serum. This is the first quantification of 1,25(OH)2D3-23,26-lactone (7) in human serum.
Open AccessSynthesis of Deuterium-Labeled Vitamin D Metabolites as Internal Standards for LC-MS Analysis
Blood levels of the vitamin D3 (D3) metabolites 25-hydroxyvitamin D3 (25(OH)D3), 24R,25-dihydroxyvitamin D3, and 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3) are recognized indicators for the diagnosis of bone metabolism-related diseases, D3 deficiency-related diseases, and hypercalcemia, and are generally measured by liquid-chromatography tandem mass spectrometry (LC-MS/MS) using an isotope dilution method. However, other D3 metabolites, such as 20-hydroxyvitamin D3 and lactone D3, also show interesting biological activities and stable isotope-labeled derivatives are required for LC-MS/MS analysis of their concentrations in serum. Here, we describe a versatile synthesis of deuterium-labeled D3 metabolites using A-ring synthons containing three deuterium atoms. Deuterium-labeled 25(OH)D3 (2), 25(OH)D3-23,26-lactone (6), and 1,25(OH)2D3-23,26-lactone (7) were synthesized, and successfully applied as internal standards for the measurement of these compounds in pooled human serum. This is the first quantification of 1,25(OH)2D3-23,26-lactone (7) in human serum.